Pharmaceutical firms set their sights on 10% sales growth in 2004

Published: 2003-10-31 06:55:00

Updated: 2003-10-31 06:55:00

With the continued downturn in the economy affecting the pharmaceutical market in a negative way, the majority of domestic pharmaceutical firms have swifted to stable growth from rapid growth by setting their 2004 sales growth target at 10 percent, which was lower than last year's 20 percent leve...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK